Search Results 1831-1840 of 20021 for Receptor
- History of type 1 diabetes. - Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period from 90 days prior to the screening visit ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer.
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer. T-cell receptor diversity may be key to treatment of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.